Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Tyra Biosciences, Inc. Common Stock (TYRA)

Pharmaceutical Preparations

https://www.tyra.bio

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. Its lead product candidate is TYRA-300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

2656 STATE STREET
CARLSBAD, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/15/2021

Market Cap

1,172,858,826

Shares Outstanding

43,060,000

Weighted SO

43,058,747

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

1.0190

Last Div

0.0000

Range

10.38-24.25

Chg

0.2400

Avg Vol

170469

Mkt Cap

1172858826

Exch

NASDAQ

Country

US

Phone

619 728 4760

DCF Diff

21.0238

DCF

1.2062

Div Yield

0.0000

P/S

2336.3722

EV Multiple

-11.3637

P/FV

3.4698

Div Yield %

0.0000

P/E

-16.1332

PEG

0.5088

Payout

0.0000

Current Ratio

36.4645

Quick Ratio

36.4645

Cash Ratio

9.5829

DSO

1381.4741

DIO

0.0000

Op Cycle

1381.4741

DPO

1332.4190

CCC

49.0551

Gross Margin

0.1394

Op Margin

-190.1414

Pretax Margin

-161.1076

Net Margin

-161.1076

Eff Tax Rate

-0.0655

ROA

-0.2061

ROE

-0.2713

ROCE

-0.2498

NI/EBT

1.0000

EBT/EBIT

0.8473

EBIT/Rev

-190.1414

Debt Ratio

0.0163

D/E

0.0170

LT Debt/Cap

0.0157

Total Debt/Cap

0.0167

Int Coverage

-38.8961

CF/Debt

-9.8395

Equity Multi

1.0437

Rec Turnover

0.2642

Pay Turnover

0.2739

Inv Turnover

0.0000

FA Turnover

0.0613

Asset Turnover

0.0013

OCF/Share

-1.0732

FCF/Share

-1.0952

Cash/Share

6.3713

OCF/Sales

-125.4243

FCF/OCF

1.0205

CF Coverage

-9.8395

ST Coverage

-164.3943

CapEx Coverage

-48.7330

Div&CapEx Cov

-48.7330

P/BV

3.4698

P/B

3.4698

P/S

2336.3722

P/E

-16.1332

P/FCF

-18.2532

P/OCF

-20.7232

P/CF

-20.7232

PEG

0.5088

P/S

2336.3722

EV Multiple

-11.3637

P/FV

3.4698

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation